VitroLabs is a biotech company developing a scalable tissue‑engineering platform to produce leather from only a few animal cells using advanced tissue engineering and proprietary process design. The company, led by CEO Ingvar Helgason and stem cell scientist Dr. Dusko Ilic, has been pioneering this material since 2016. It reports progress on product quality, optimization of cell expansion processes, and the proprietary design of a novel large‑scale tissue cultivator. Last fall VitroLabs moved into a new 45,000 square foot facility designed for pilot production and laboratory space as it advances toward commercialization. The company plans to use the new funding to fast‑track commercialization and expand its scientific, manufacturing, and business development teams. Kering continues a partnership supporting product quality testing, tanning, and finishing.

Total raised

$46M

Funding rounds

1

Latest round

Series A

Latest activity

May 2022